The Board of Directors of Yamane Medical Co., Ltd. (JASDAQ:2144) authorized a share repurchase program on August 1, 2012. Under the program, the company will repurchase up to 500 shares, representing 0.46% of its outstanding share capital (excluding treasury shares), for a total cost of up to ¥15 million. Repurchases will be made between August 2, 2012 and January 31, 2013. As of August 1, 2012, the company has 109,645 shares outstanding (excluding treasury shares) and 3,655 shares held in treasury.

Yamane Medical Co., Ltd.'s share repurchase program expired on January 31, 2013. Under the plan, the company has repurchased 144 shares, representing 0.13% for ¥3.64 million.